Evidence map›Paper›PMID 20832196›Full record

Trial reportDrug and alcohol dependence2011

Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.

Karina M Berg, Alain Litwin, Xuan Li, Moonseong Heo, Julia H Arnsten

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05039554 (Randomized Trial of Acceptance and Commitment Therapy), which is not on this map. Cited by 76 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 13 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05039554 naactive not recruitingnot on this mapstarted 2023, after this paper: background citation

Randomized Trial of Acceptance and Commitment Therapy (ACT) and a Care Management App in Primary Care-based Buprenorphine Treatment

TypeinterventionalSponsorAlbert Einstein College of MedicineRan2023 to 2027Enrolled125ConditionsOpioid-use Disorder, Chronic PainArmsAcceptance and commitment therapy, Valera Smartphone Application, Treatment as Usual
3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 13 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Pooled it
  8. Interventions for enhancing medication adherence.The Cochrane database of systematic reviews · 2014
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Guideline
  12. Pooled it
  13. Guideline
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Karina M BergDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10467, United States.
Alain Litwin
Xuan Li
Moonseong Heo
Julia H Arnsten

Funding

Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI KLEIN, ROBERT STEPHEN · 2003 to 2013
$18.6M
Efficacy and cost of HAART DOT in methadone clinicsR01DA015302 · NIDA · YESHIVA UNIVERSITY · PI ARNSTEN, JULIA H · 2003 to 2007
$4.8M
HIV and Substance Abuse Clinical Addiction Research and Education (CARE) ProgramR25DA023021 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ARNSTEN, JULIA H. · 2007 to 2014
$2.7M
CLINICAL ADDICTION RESEARCH AND EDUCATION (CARE) PROGRAMR25DA014551 · NIDA · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ARNSTEN, JULIA H. · 2002 to 2005
$1.3M
Improving Measurement of Antiretroviral Adherence in Current and Former Drug UserK23DA021087 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BERG, KARINA M · 2006 to 2009
$647k
NIAID NIH HHS P30 AI051519NIDA NIH HHS K23 DA021087NIDA NIH HHS R01 DA015302NIDA NIH HHS R25 DA014551NIDA NIH HHS R25 DA023021
6 · The paper itself

Abstract

objectiveTo determine if directly observed antiretroviral therapy (DOT) is more efficacious than self-administered therapy for improving adherence and reducing HIV viral load (VL) among methadone-maintained opioid users.

designTwo-group randomized trial.

settingTwelve methadone maintenance clinics with on-site HIV care in the Bronx, New York.

participantsHIV-infected adults prescribed combination antiretroviral therapy. MAIN OUTCOMES MEASURES: Between group differences at four assessment points from baseline to week 24 in: (1) antiretroviral adherence measured by pill count, (2) VL, and (3) proportion with undetectable VL (< 75 copies/ml).

resultsBetween June 2004 and August 2007, we enrolled 77 participants. Adherence in the DOT group was higher than in the control group at all post-baseline assessment points; by week 24 mean DOT adherence was 86% compared to 56% in the control group (p < 0.0001). Group differences in mean adherence remained significant after stratifying by baseline VL (detectable versus undetectable). In addition, during the 24-week intervention, the proportion of DOT participants with undetectable VL increased from 51% to 71%.

conclusionsAmong HIV-infected opioid users, antiretroviral DOT administered in methadone clinics was efficacious for improving adherence and decreasing VL, and these improvements were maintained over a 24-week period. DOT should be more widely available to methadone patients.

Indexed as

Drug MonitoringAntiretroviral Therapy, Highly ActiveDirectly Observed TherapyFemaleHIV InfectionsHumansMaleMethadoneMiddle AgedOpiate Substitution TreatmentOpioid-Related DisordersSubstance Abuse Treatment CentersViral LoadMethadone

Identifiers

PMID20832196
PMCPMC3003759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.